tiprankstipranks
Astrazeneca Plc (AZN)
NASDAQ:AZN
Holding AZN?
Track your performance easily

AstraZeneca (AZN) Earnings Date & Reports

6,635 Followers

Earnings Data

Report Date
Feb 06, 2025
Before Open Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
$1.06
Last Year’s EPS
$0.73
Same Quarter Last Year
Based on 6 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 12, 2024
|
% Change Since: 0.86%
|
Next Earnings Date:Feb 06, 2025
Earnings Call Sentiment|Positive
The earnings call presented a strong performance with significant revenue growth across regions and sectors, an upgraded full-year guidance, and promising pipeline developments. However, uncertainties in China due to ongoing investigations, potential impacts from Farxiga's VBP inclusion, and IRA headwinds pose challenges. Despite these concerns, the overall sentiment remains optimistic with strategic investments and a robust R&D pipeline.
Company Guidance
In the recent Q3 2024 earnings call, AstraZeneca provided updated guidance reflecting strong financial performance. Total revenue for the third quarter increased by 21%, driven by robust global demand, with core EPS rising 27% to $2.08. Year-to-date, revenue grew 19%, and core EPS grew 11%, bolstered by previous one-time revenues totaling $1.1 billion. Notably, all therapeutic areas reported double-digit growth, leading to an upgraded full-year guidance expecting revenue and core EPS growth in the high teens. Furthermore, AstraZeneca announced a $3.5 billion investment in U.S. manufacturing and R&D to support future growth, underlining its commitment to expanding its presence in the U.S. market.
Significant Revenue Growth
Total revenue grew by 21% in Q3 and by 19% year-to-date, with core EPS increasing by 11%.
Upgrade in Full Year Guidance
Full-year guidance upgraded with expectations for both total revenue and core EPS to grow by high teens percentage.
Strong Oncology Performance
Oncology total revenues grew 22% to $16 billion, driven by strong demand in the U.S., Europe, and emerging markets.
Emerging Markets Growth
Emerging markets outside of China showed a standout performance with 30% growth year-to-date.
New Investments in the U.S.
Announced a $3.5 billion investment in the U.S. for manufacturing and R&D to support future growth.
Positive R&D Pipeline Developments
Multiple high-value Phase III readouts with potential new indications and therapies across various areas.
---

AstraZeneca (AZN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

AZN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 06, 20252024 (Q4)
1.06 / -
0.725
Nov 12, 20242024 (Q3)
1.02 / 1.04
0.86520.23% (+0.18)
Jul 25, 20242024 (Q2)
0.98 / 0.99
1.075-7.91% (-0.08)
Apr 25, 20242024 (Q1)
0.96 / 1.03
0.967.29% (+0.07)
Feb 08, 20242023 (Q4)
0.73 / 0.72
0.695.07% (+0.04)
Nov 09, 20232023 (Q3)
0.84 / 0.86
0.8353.59% (+0.03)
Jul 28, 20232023 (Q2)
0.99 / 1.07
0.8625.00% (+0.21)
Apr 27, 20232023 (Q1)
0.85 / 0.96
0.9451.59% (+0.02)
Feb 09, 20232022 (Q4)
0.67 / 0.69
0.835-17.37% (-0.15)
Nov 10, 20222022 (Q3)
0.76 / 0.83
0.5454.63% (+0.29)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

AZN Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 12, 2024$64.79$65.19+0.62%
Jul 25, 2024$79.23$78.05-1.49%
Apr 25, 2024$70.77$74.58+5.38%
Feb 08, 2024$65.17$62.20-4.56%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Astrazeneca Plc (AZN) report earnings?
Astrazeneca Plc (AZN) is schdueled to report earning on Feb 06, 2025, Before Open Not Confirmed.
    What is Astrazeneca Plc (AZN) earnings time?
    Astrazeneca Plc (AZN) earnings time is at Feb 06, 2025, Before Open Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is AZN EPS forecast?
          AZN EPS forecast for the fiscal quarter 2024 (Q4) is $1.06.
            ---

            AstraZeneca (AZN) Earnings News

            AstraZeneca (AZN) Q3 Earnings: Here’s What to Expect
            Premium
            Market News
            AstraZeneca (AZN) Q3 Earnings: Here’s What to Expect
            1M ago
            AZN Earnings: AstraZeneca Soars on Impressive Q1 Results
            Premium
            Market News
            AZN Earnings: AstraZeneca Soars on Impressive Q1 Results
            8M ago
            AstraZeneca (NASDAQ:AZN) Rises on Healthy Q4 Performance
            Premium
            Market News
            AstraZeneca (NASDAQ:AZN) Rises on Healthy Q4 Performance
            11M ago
            AstraZeneca (NASDAQ:AZN) Rises on Impressive Q3 Momentum
            Premium
            Market News
            AstraZeneca (NASDAQ:AZN) Rises on Impressive Q3 Momentum
            1y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis